BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 12919638)

  • 1. Endoscopic sclerotherapy compared with no specific treatment for the primary prevention of bleeding from esophageal varices. A randomized controlled multicentre trial [ISRCTN03215899].
    van Buuren HR; Rasch MC; Batenburg PL; Bolwerk CJ; Nicolai JJ; van der Werf SD; Scherpenisse J; Arends LR; van Hattum J; Rauws EA; Schalm SW
    BMC Gastroenterol; 2003 Aug; 3():22. PubMed ID: 12919638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preventive sclerotherapy of esophageal varices with a high risk of hemorrhage: a prospective randomized controlled study].
    Svoboda P; Kantorová I; Ochmann J; Kozumplík L; Marsová J
    Rozhl Chir; 1999 Jul; 78(7):337-42. PubMed ID: 10596569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: a lesson from the past.
    Santambrogio R; Opocher E; Costa M; Bruno S; Ceretti AP; Spina GP
    World J Gastroenterol; 2006 Oct; 12(39):6331-8. PubMed ID: 17072957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary prevention of digestive hemorrhage, caused by rupture of esophageal varices, by endoscopic sclerotherapy in patients with liver cirrhosis. Multicenter randomized controlled study].
    Duhamel O; Carle JP; Daures JP; Boyer A; Gislon J; Nalet B; Cassan P; Dubois A; Raffanel C; Balmes JL
    Gastroenterol Clin Biol; 1994; 18(1):57-62. PubMed ID: 8187990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
    Gattini D; Cifuentes LI; Torres-Robles R; Gana JC
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD011573. PubMed ID: 32133620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.
    Roccarina D; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Benmassaoud A; Plaz Torres MC; Iogna Prat L; Csenar M; Arunan S; Begum T; Milne EJ; Tapp M; Pavlov CS; Davidson BR; Tsochatzis E; Williams NR; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013121. PubMed ID: 33822357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis.
    Sauerbruch T; Wotzka R; Köpcke W; Härlin M; Heldwein W; Bayerdörffer E; Sander R; Ansari H; Starz I; Paumgartner G
    N Engl J Med; 1988 Jul; 319(1):8-15. PubMed ID: 3288871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic sclerotherapy for esophageal varices in high-risk cirrhotic patients selected by endoscopic and hemodynamic criteria: a randomized, single-center controlled trial.
    Paquet KJ; Kalk JF; Klein CP; Gad HA
    Endoscopy; 1994 Nov; 26(9):734-40. PubMed ID: 7712967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerotherapy on liver cirrhosis with esophageal variceal bleeding: eight years of experience.
    Cheng CY; Chen GH; Chang CS; Tseng CC; Chen TY; Lin CK; Pan HK; Huang CK; Hsieh PF; Huang PT
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov; 54(5):321-8. PubMed ID: 7834554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic sclerotherapy in children with esophageal varices: long-term results of a controlled prospective randomized trial.
    Gonçalves ME; Cardoso SR; Maksoud JG
    J Pediatr Surg; 2000 Mar; 35(3):401-5. PubMed ID: 10726678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic sclerotherapy for esophageal varices: long-term results of a prospective study.
    Koch H; Binmoeller KF; Grimm H; Soehendra N; Henning H; Oehler G
    Endoscopy; 1994 Nov; 26(9):729-33. PubMed ID: 7712966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of endoscopic ligation plus cyanoacrylate injection with or without sclerotherapy for variceal bleeding.
    Chen J; Zeng XQ; Ma LL; Huang XQ; Tseng YJ; Wang J; Luo TC; Chen SY
    J Dig Dis; 2016 Apr; 17(4):252-9. PubMed ID: 26896761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices.
    Svoboda P; Kantorová I; Ochmann J; Kozumplík L; Marsová J
    Surg Endosc; 1999 Jun; 13(6):580-4. PubMed ID: 10347295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding.
    Russo MW; Zacks SL; Sandler RS; Brown RS
    Hepatology; 2000 Feb; 31(2):358-63. PubMed ID: 10655258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic sclerotherapy of high-risk esophageal varices: results of a multicentric prospective controlled trial.
    Piai G; Cipolletta L; Claar M; Marone G; Bianco MA; Forte G; Iodice G; Mattera D; Minieri M; Rocco P
    Hepatology; 1988; 8(6):1495-500. PubMed ID: 3056821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial.
    Cello JP; Ring EJ; Olcott EW; Koch J; Gordon R; Sandhu J; Morgan DR; Ostroff JW; Rockey DC; Bacchetti P; LaBerge J; Lake JR; Somberg K; Doherty C; Davila M; McQuaid K; Wall SD
    Ann Intern Med; 1997 Jun; 126(11):858-65. PubMed ID: 9163286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of prophylactic sclerotherapy in patients with hepatocellular carcinoma and varices negative for the red color sign.
    Miyoshi H; Matsumoto A; Oka M; Sugi K; Yoshimura K; Hongou Y; Katsu K
    Gastrointest Endosc; 1997 Jun; 45(6):498-502. PubMed ID: 9199908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merits of prophylactic sclerotherapy for esophageal varices concomitant unresectable hepatocellular carcinoma: prospective randomized study.
    Akahoshi T; Tomikawa M; Tsutsumi N; Hashizume M; Maehara Y
    Dig Endosc; 2014 Mar; 26(2):172-7. PubMed ID: 23650913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial comparing endoscopic ligation with or without sclerotherapy for secondary prophylaxis of variceal bleeding.
    Chen J; Zeng XQ; Ma LL; Li B; Tseng YJ; Lian JJ; Gao H; Wang J; Luo TC; Chen SY
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):95-100. PubMed ID: 26517621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argon plasma coagulation prevents variceal recurrence after band ligation of esophageal varices: preliminary results of a prospective randomized trial.
    Cipolletta L; Bianco MA; Rotondano G; Marmo R; Meucci C; Piscopo R
    Gastrointest Endosc; 2002 Oct; 56(4):467-71. PubMed ID: 12297759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.